ReviewTherapeutic advances in chronic disease2018

Safety and tolerability of adalimumab for the treatment of psoriasis: a review summarizing 15 years of real-life experience.

Paul SatorPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.